10 Dec 2019 | 8:35 AM


Medicamen Biotec Q2 net profit up 7.87% at Rs 3.84 cr
  Medicamen Biotech Ltd. | 09 Dec 2019 | 04:01 PM
Published on 11-08-2019
The company reported standalone net profit of Rs 3.84 crore for the quarter ended September 30 2019 as compared to Rs 3.56 crore in the same period last year registering a year-on-year growth of 7.87 per cent.

Net revenue of the company rose moderately by 9.33 per cent at Rs 35.52 crore in July-September quarter of this fiscal as against Rs 32.49 crore in the corresponding period last year.

During July-September quarter operating expenses increased by 5.15 per cent to Rs 29.81 crore from Rs 28.35 crore in year ago period.

Other Income dipped by 80.66 per cent at Rs 0.35 crore versus (Sep`18 Rs 1.81 crore).

Operating Profit surged by 37.68 per cent to Rs 5.70 crore as against Rs 4.14 crore in the year ago period while Operating Profit Margin (OPM) expanded year-on-year to 26.06 per cent in September quarter.

Interest declined by 40.00 per cent y-o-y to Rs 0.21 crore while Taxation decreased by 10.97 per cent at Rs 1.38 crore (Sep`18 Rs 1.55 crore).